Gentherm (THRM)
Builds thermal and pneumatic comfort systems for vehicles, plus patient-temperature-management products.
Something off on this page? Send us feedback.
Supplies climate-controlled seating, interior thermal comfort, lumbar and massage systems, valve systems, electronics, and medical patient-temperature-management products. Automotive work produces almost all revenue and is tied to global vehicle programs, seating integrators, OEM demand, and acquisition integration.
Supplies thermal-management and comfort systems mainly to automotive programs. Automotive products include Climate Control Seats, Climate Control Interiors, Lumbar and Massage Comfort Solutions, Climate and Comfort Electronics, Valve Systems, and other vehicle components.
Medical adds patient-temperature-management systems used across care settings. The business operates through a global manufacturing and engineering footprint, with activity tied to automakers and seat-system integrators across North America, Europe, and Asia.
Execution depends on vehicle production schedules, platform awards, large seating customers, OEM demand, acquisition integration, and the pending Modine Performance Technologies transaction. The current portfolio is shaped by acquisitions that expanded from thermoelectric seating into pneumatic comfort, electronics, valves, and patient temperature management.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 15, 2026 | JP Morgan | Upgrade | ||
| Sep 14, 2026 | CJS Securities | Initiate | Rating: — | |
| Jul 29, 2026 | Roth Capital | Reiterate | Rating: —Target: $44 | Target: $50 |
| Jul 24, 2026 | Stifel Nicolaus | Target | Target: $44 | Target: $59 |
| Jul 24, 2026 | Freedom Broker | Downgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $213.2M · Total debt $325.1M · Total assets $1.49B · Shareholders' equity $723.1M
- Revenue
- $416.2M
- Operating income
- $10.7M
- Net income
- $4.4M
| Institutions | 107.48% | 33.00M shares | |
|---|---|---|---|
| 260 holders · as of Jun 30, 2026 | |||
| Insiders | 2.65% | 812.3K shares | |
| 20 holders · as of Aug 18, 2026 | |||
| Adds to | 110.13% | ||
30.71M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 110.13%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 15.75% | 4.84M | as of Jun 30, 2026 |
Van Berkom & Associates Inc.Institution | 6.74% | 2.07M | filed Feb 11, 2019 |
Vanguard Portfolio Management LLCInstitution | 6.30% | 1.93M | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 5.11% | 1.57M | as of Jun 30, 2026 |
Harvey Partners, LLCInstitution | 4.32% | 1.33M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Breisacher Nicholas | officer: Chief Accounting Officer | −925 | $43.21 |
| Jul 29, 2026 | Wayne S. III Kauffman | officer: SVP and General Counsel | −4,700 | $43.21 |
- Lear
Direct seating thermal-comfort challenger with ComfortMax
- Adient
Complete-seat scale with modular heat, ventilation, and massage features
- Magna
Seating Systems scale around OEM seat-platform awards
- BorgWarner
Propulsion thermal systems and electric heaters overlap in EV content
- Solventum
Bair Hugger patient warming platform for perioperative protocols
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Gentherm | $36.93 | +1.81% | $1.11B | 41.9 | 12.6 | 0.7 | +11.0% |
| Lear | $122.15 | +1.60% | $6.02B | 11.2 | 7.8 | 0.3 | +3.0% |
| Adient | $18.03 | +3.26% | $1.37B | 29.1 | 7.1 | 0.1 | +5.0% |
| Magna | $63.33 | +0.51% | $17.15B | 23.3 | 8.6 | 0.4 | +2.0% |
| BorgWarner | $61.07 | −3.55% | $12.99B | 31.2 | 11.2 | 0.9 | +0.3% |
| Solventum | $89.18 | +0.38% | $15.38B | 10.8 | 13.1 | 1.9 | +2.2% |
| Median | 23.3 | 8.6 | 0.4 | +2.2% |